What we've approved

Dealings involving intentional release

Details on the applications and licences for Dealings involving an intentional release (DIR) of a GMO into the environment.

Dealings involving an Intentional Release (DIR) of GMOs into the environment are dealings with GMOs which can take place outside of containment facilities.

Filter results

You can narrow down the results using the filters

Licence status

Current (1)
Surrendered (2)

Category

Medical (3)

Release

Commercial (2)
Limited and controlled (1)

Dealings involving an Intentional Release (DIR) of GMOs into the environment are dealings with GMOs which can take place outside of containment facilities.

3 results
Licence number Project title Organisation Category Release Issue date Licence status
DIR 184

Clinical trial with a genetically modified human adenovirus COVID-19 vaccine

Avance Clinical Pty Ltd

 Medical Limited and controlled Current
DIR 182

Commercial supply of a genetically modified COVID-19 vaccine

Janssen-Cilag Pty Ltd

 Medical Commercial Surrendered
DIR 180

Commercial supply of a genetically modified COVID-19 vaccine

AstraZeneca Pty Ltd

 Medical Commercial Surrendered